Download Files:
Products Details
Product Description
– Y13g is the potent inhibitor of both AChE and IL-6. Interleukin-6 (IL-6) and acetylcholinesterase (AChE) are two important targets implicated in progression of Alzheimer’s Disease (AD). Y13g reverses the STZ-induced memory deficit, and shows histopathology similarly as in normal animals[1].
Web ID
– HY-115910
Shipping
– Room temperature
Applications
– Neuroscience-Neurodegeneration
Molecular Formula
– C16H24N2O4
References
– [1]Kaur S, et al. Design, molecular Docking, synthesis and evaluation of xanthoxylin hybrids as dual inhibitors of IL-6 and acetylcholinesterase for Alzheimer’s disease. Bioorg Chem. 2022;121:105670.
CAS Number
– 2766380-73-6
Molecular Weight
– 308.37
SMILES
– COC1=CC(O)=C(C(OC)=C1)C(CCCN2CCNCC2)=O
Clinical Information
– No Development Reported
Research Area
– Neurological Disease
Solubility
– 10 mM in DMSO
Target
– Cholinesterase (ChE);Interleukin Related
Isoform
– AChE;IL-6
Pathway
– Immunology/Inflammation;Neuronal Signaling
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
